A recent study compared [61Cu]Cu-NODAGA-PSMA-I&T and [61Cu]Cu-DOTAGA-PSMA-I&T, with the NODAGA-conjugated radioligand showing higher tumor uptake, lower background activity, and reduced nonspecific accumulation in the liver and abdominal region [106]. Here, FOLH1 is linked to neoplasm.